Trial site
The First Affiliated Hospital, College of Medicine, Zhejiang University
- 34running trials
- 11closed trials
The trials here
What the 45 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers9 trials
- Multiple myeloma7 trials
- Acute myeloid leukaemia6 trials
- Gastric and oesophageal cancer6 trials
- Acute lymphoblastic leukaemia5 trials
- Chronic kidney disease3 trials
- Liver and biliary tract cancer3 trials
- ANCA-associated vasculitis2 trials
- Myelodysplastic syndromes2 trials
- Colorectal cancer1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- and 4 more
- Phase
- Phase 316 trials
- Phase 29 trials
- Early phase 18 trials
- Phase 17 trials
- Phase 1/23 trials
- Status
- Recruiting17 trials
- Completed11 trials
- Not yet recruiting10 trials
- Active, not recruiting7 trials
- Lead sponsor
- Zhejiang University9 trials
- First Affiliated Hospital of Zhejiang University5 trials
- Yu jiren4 trials
- Ascentage Pharma Group Inc.2 trials
- Haisco Pharmaceutical Group Co., Ltd.2 trials
- and 22 more
Running trials
Not yet recruiting
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
Recruiting
Recruiting
Recruiting
Recruiting
LineMatrix® Biological Vascular Graft for the Creation of Arteriovenous Graft
Recruiting
Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
Not yet recruiting
Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT
Active, not recruiting
A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
Recruiting
A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
Recruiting
Recruiting
Recruiting
Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL
Active, not recruiting
A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)
Recruiting
Recruiting
A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)
Recruiting
Recruiting
OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Not yet recruiting
NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia
Not yet recruiting
LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers7 recruiting
- Multiple myeloma6 recruiting
- Acute myeloid leukaemia5 recruiting
- Gastric and oesophageal cancer4 recruiting
- Acute lymphoblastic leukaemia3 recruiting
- ANCA-associated vasculitis1 recruiting
- Chronic kidney disease1 recruiting
- Colorectal cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Efficacy and Safety of HSK39297 in Anti-C5 Treated PNH Patients With Anemia
Completed
Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes
Completed
Completed
Completed
Completed
Completed
Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph+ B-ALL
Completed
Completed
Completed
Completed
A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma
Site data: ClinicalTrials.govUpdated 19 Nov 2026